Company OverviewAditxt Inc.
Aditxt Inc. (NASDAQ: ADTX) is a life sciences company developing technologies specifically focused on improving the health of the immune system through immune reprogramming and monitoring. Our immune reprogramming technology called Apoptotic DNA Immunotherapy™ (ADi™) is designed to retrain the immune system to induce tolerance with an objective of addressing rejection of transplanted organs, autoimmune diseases, and allergies. Our immune monitoring technology called Aditxt Immune Monitor™ (AiM™) is designed to provide a personalized comprehensive profile of the immune system.
Speaker BioCo-Founder & CEO
Aditxt Inc.
Founded eight startups to commercialize innovations in various industries including enterprise software, research incubation, GPS & wireless, nano sensors, consumer health and biotech. Led multiple M&A and going-public transactions as a founder, co-founder and/or senior executive.
